Efficacy and Safety of Once-Daily Darunavir/Ritonavir Versus Lopinavir/Ritonavir in Treatment-Naive HIV-1-Infected Patients at Week 48. AIDS, 22(12): 1389-1397.
Author:
Andrade-Villanueva J, De Meyer S, De Pauw M, DeJesus E, Fourie J, Khanlou H, Lefebvre E, Ortiz R, Spinosa-Guzman S, van Lunzen J, Vangeneugden T, Voronin E
This website uses cookies to improve your experience. We’ll assume you’re ok with this, but you can opt-out if you wish. [cookie_settings] [cookie_button]